Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.72537627 |
2 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 6.59937886 |
3 | negative regulation of cell killing (GO:0031342) | 6.36718145 |
4 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.36718145 |
5 | daunorubicin metabolic process (GO:0044597) | 6.18476370 |
6 | polyketide metabolic process (GO:0030638) | 6.18476370 |
7 | doxorubicin metabolic process (GO:0044598) | 6.18476370 |
8 | positive regulation by symbiont of host defense response (GO:0052509) | 6.14430941 |
9 | modulation by symbiont of host defense response (GO:0052031) | 6.14430941 |
10 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.14430941 |
11 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.14430941 |
12 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.14430941 |
13 | modulation by symbiont of host immune response (GO:0052553) | 6.14430941 |
14 | carnitine shuttle (GO:0006853) | 5.47947824 |
15 | neutrophil activation involved in immune response (GO:0002283) | 5.47576709 |
16 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 5.43771603 |
17 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.41366444 |
18 | actin-myosin filament sliding (GO:0033275) | 5.23278795 |
19 | muscle filament sliding (GO:0030049) | 5.23278795 |
20 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.17043125 |
21 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.16399107 |
22 | cytidine deamination (GO:0009972) | 5.04678210 |
23 | cytidine metabolic process (GO:0046087) | 5.04678210 |
24 | cytidine catabolic process (GO:0006216) | 5.04678210 |
25 | regulation of skeletal muscle contraction (GO:0014819) | 5.01679576 |
26 | macrophage activation involved in immune response (GO:0002281) | 4.99588047 |
27 | detection of other organism (GO:0098543) | 4.95837423 |
28 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.90012135 |
29 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.83043277 |
30 | fatty acid transmembrane transport (GO:1902001) | 4.82198048 |
31 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.79889642 |
32 | detection of bacterium (GO:0016045) | 4.79542366 |
33 | regulation of response to osmotic stress (GO:0047484) | 4.78537393 |
34 | sarcomere organization (GO:0045214) | 4.78195667 |
35 | tricarboxylic acid cycle (GO:0006099) | 4.69790793 |
36 | oxygen transport (GO:0015671) | 4.69086715 |
37 | plasma membrane repair (GO:0001778) | 4.54041338 |
38 | carnitine transmembrane transport (GO:1902603) | 4.46010333 |
39 | response to interleukin-15 (GO:0070672) | 4.43675039 |
40 | neutrophil activation (GO:0042119) | 4.41822718 |
41 | detection of external biotic stimulus (GO:0098581) | 4.30093299 |
42 | response to peptidoglycan (GO:0032494) | 4.29404922 |
43 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.28980102 |
44 | cellular extravasation (GO:0045123) | 4.28403796 |
45 | myofibril assembly (GO:0030239) | 4.25480313 |
46 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.22030455 |
47 | detection of molecule of bacterial origin (GO:0032490) | 4.21778195 |
48 | respiratory burst (GO:0045730) | 4.21332606 |
49 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.20231650 |
50 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.19441700 |
51 | cellular response to interleukin-15 (GO:0071350) | 4.18701304 |
52 | leukocyte aggregation (GO:0070486) | 4.18571793 |
53 | carnitine transport (GO:0015879) | 4.15905388 |
54 | amino-acid betaine transport (GO:0015838) | 4.15905388 |
55 | biotin metabolic process (GO:0006768) | 4.15525314 |
56 | actin-mediated cell contraction (GO:0070252) | 4.14991355 |
57 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.13473898 |
58 | regulation of sequestering of triglyceride (GO:0010889) | 4.13155880 |
59 | negative regulation of interleukin-12 production (GO:0032695) | 4.07579087 |
60 | response to host immune response (GO:0052572) | 4.04630775 |
61 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.04630775 |
62 | hormone catabolic process (GO:0042447) | 4.03284295 |
63 | granulocyte activation (GO:0036230) | 4.01259313 |
64 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.91812328 |
65 | neutrophil mediated immunity (GO:0002446) | 3.91293331 |
66 | positive regulation of histone deacetylation (GO:0031065) | 3.90117362 |
67 | microglial cell activation (GO:0001774) | 3.89909515 |
68 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.84280864 |
69 | regulation of gamma-delta T cell activation (GO:0046643) | 3.82556493 |
70 | regulation of mast cell degranulation (GO:0043304) | 3.81956399 |
71 | gas transport (GO:0015669) | 3.81537989 |
72 | maintenance of protein location in nucleus (GO:0051457) | 3.79403344 |
73 | cardiac myofibril assembly (GO:0055003) | 3.77560848 |
74 | myeloid cell activation involved in immune response (GO:0002275) | 3.77461998 |
75 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.76240915 |
76 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.75375052 |
77 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.75278021 |
78 | negative regulation of phagocytosis (GO:0050765) | 3.72281738 |
79 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.69212435 |
80 | response to host (GO:0075136) | 3.69212435 |
81 | response to host defenses (GO:0052200) | 3.69212435 |
82 | detection of biotic stimulus (GO:0009595) | 3.68744496 |
83 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.66445191 |
84 | porphyrin-containing compound biosynthetic process (GO:0006779) | 3.65885188 |
85 | skeletal muscle adaptation (GO:0043501) | 3.64907155 |
86 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.64623376 |
87 | macrophage activation (GO:0042116) | 3.64536626 |
88 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 3.61700175 |
89 | skeletal muscle contraction (GO:0003009) | 3.59801652 |
90 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.59543149 |
91 | negative regulation of cell size (GO:0045792) | 3.58377902 |
92 | striated muscle contraction (GO:0006941) | 3.57857957 |
93 | muscle organ morphogenesis (GO:0048644) | 3.56902792 |
94 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.52583258 |
95 | immunoglobulin mediated immune response (GO:0016064) | 3.52399718 |
96 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.48297460 |
97 | negative regulation of T cell mediated immunity (GO:0002710) | 3.47090612 |
98 | leukocyte degranulation (GO:0043299) | 3.44737340 |
99 | NADH metabolic process (GO:0006734) | 3.44489873 |
100 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.44453372 |
101 | regulation of fatty acid oxidation (GO:0046320) | 3.44338074 |
102 | regulation of cofactor metabolic process (GO:0051193) | 3.43110956 |
103 | regulation of coenzyme metabolic process (GO:0051196) | 3.43110956 |
104 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.38450927 |
105 | coenzyme catabolic process (GO:0009109) | 3.36508207 |
106 | positive regulation of mast cell activation (GO:0033005) | 3.36238454 |
107 | positive regulation of protein deacetylation (GO:0090312) | 3.35655608 |
108 | glycolytic process (GO:0006096) | 3.33009967 |
109 | regulation of leukocyte degranulation (GO:0043300) | 3.32359623 |
110 | epoxygenase P450 pathway (GO:0019373) | 3.31941575 |
111 | quaternary ammonium group transport (GO:0015697) | 3.30995502 |
112 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.30677601 |
113 | cardiac muscle cell development (GO:0055013) | 3.29433358 |
114 | maternal placenta development (GO:0001893) | 3.24529219 |
115 | regulation of T cell tolerance induction (GO:0002664) | 3.24097456 |
116 | myeloid leukocyte mediated immunity (GO:0002444) | 3.23252002 |
117 | tetrapyrrole biosynthetic process (GO:0033014) | 3.22675780 |
118 | creatine metabolic process (GO:0006600) | 3.21888120 |
119 | vitamin A metabolic process (GO:0006776) | 3.21859708 |
120 | actin filament-based movement (GO:0030048) | 3.20678185 |
121 | B cell receptor signaling pathway (GO:0050853) | 3.19951255 |
122 | regulation of mast cell activation (GO:0033003) | 3.19600847 |
123 | cardiac muscle contraction (GO:0060048) | 3.18672212 |
124 | somite rostral/caudal axis specification (GO:0032525) | 3.17758508 |
125 | fatty acid beta-oxidation (GO:0006635) | 3.16007540 |
126 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.15995596 |
127 | lysine metabolic process (GO:0006553) | 3.15272984 |
128 | lysine catabolic process (GO:0006554) | 3.15272984 |
129 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.15119559 |
130 | cellular response to type I interferon (GO:0071357) | 3.13314511 |
131 | type I interferon signaling pathway (GO:0060337) | 3.13314511 |
132 | germinal center formation (GO:0002467) | 3.12325841 |
133 | valine metabolic process (GO:0006573) | 3.11756883 |
134 | glycogen catabolic process (GO:0005980) | 3.11300419 |
135 | response to type I interferon (GO:0034340) | 3.11120020 |
136 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.10825709 |
137 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 3.10542446 |
138 | glucan catabolic process (GO:0009251) | 3.09798803 |
139 | cellular response to osmotic stress (GO:0071470) | 3.09395748 |
140 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.05979152 |
141 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 3.05739748 |
142 | cardiac cell development (GO:0055006) | 3.04844256 |
143 | regulation of B cell differentiation (GO:0045577) | 3.04500128 |
144 | cellular modified amino acid catabolic process (GO:0042219) | 3.03968581 |
145 | regulation of tolerance induction (GO:0002643) | 3.03791341 |
146 | negative regulation of interleukin-6 production (GO:0032715) | 3.03591734 |
147 | tolerance induction (GO:0002507) | 3.02597754 |
148 | regulation of platelet aggregation (GO:0090330) | 3.02229160 |
149 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.01576357 |
150 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.00800134 |
151 | actomyosin structure organization (GO:0031032) | 3.00259135 |
152 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.98214500 |
153 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.95826442 |
154 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.95793585 |
155 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.95410299 |
156 | retinoic acid receptor signaling pathway (GO:0048384) | 2.95006147 |
157 | regulation of regulated secretory pathway (GO:1903305) | 2.94939257 |
158 | quinone metabolic process (GO:1901661) | 2.94208078 |
159 | porphyrin-containing compound metabolic process (GO:0006778) | 2.93709986 |
160 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.93054969 |
161 | positive thymic T cell selection (GO:0045059) | 2.91013924 |
162 | defense response to protozoan (GO:0042832) | 2.90665068 |
163 | 2-oxoglutarate metabolic process (GO:0006103) | 2.90506208 |
164 | pyruvate metabolic process (GO:0006090) | 2.90003813 |
165 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.89601191 |
166 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.89601191 |
167 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059) | 2.89397290 |
168 | dendritic cell migration (GO:0036336) | 2.88423323 |
169 | negative regulation of type 2 immune response (GO:0002829) | 2.88140226 |
170 | cellular polysaccharide catabolic process (GO:0044247) | 2.86581710 |
171 | negative regulation of telomerase activity (GO:0051974) | 2.86317470 |
172 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.86235445 |
173 | response to muramyl dipeptide (GO:0032495) | 2.85347734 |
174 | regulation of cilium movement (GO:0003352) | 2.84820187 |
175 | positive regulation of fatty acid oxidation (GO:0046321) | 2.84656610 |
176 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.83560497 |
177 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.83560497 |
178 | heme biosynthetic process (GO:0006783) | 2.83369487 |
179 | myeloid leukocyte activation (GO:0002274) | 2.82937577 |
180 | dendritic cell chemotaxis (GO:0002407) | 2.82715757 |
181 | long-chain fatty acid transport (GO:0015909) | 2.82154202 |
182 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.81828862 |
183 | positive regulation of granulocyte differentiation (GO:0030854) | 2.81544374 |
184 | regulation of p38MAPK cascade (GO:1900744) | 2.80808027 |
185 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.79232261 |
186 | positive regulation of B cell differentiation (GO:0045579) | 2.79142328 |
187 | receptor recycling (GO:0001881) | 2.78905210 |
188 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.78815969 |
189 | positive regulation of mast cell degranulation (GO:0043306) | 2.77642520 |
190 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.77642520 |
191 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.77288661 |
192 | muscle contraction (GO:0006936) | 2.77062910 |
193 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.76547287 |
194 | negative regulation of epidermis development (GO:0045683) | 2.74822636 |
195 | aspartate family amino acid catabolic process (GO:0009068) | 2.74303581 |
196 | mitochondrion localization (GO:0051646) | 2.72733343 |
197 | heterochromatin organization (GO:0070828) | 2.72430222 |
198 | cardiac muscle tissue morphogenesis (GO:0055008) | 2.71599092 |
199 | polysaccharide catabolic process (GO:0000272) | 2.69069433 |
200 | branched-chain amino acid catabolic process (GO:0009083) | 2.68842051 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.07519777 |
2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.57783575 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.12823801 |
4 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.53191995 |
5 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 3.45160189 |
6 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 3.45160189 |
7 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 3.45160189 |
8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.27830594 |
9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.25372558 |
10 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.89884884 |
11 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.79587442 |
12 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.74103290 |
13 | SPI1_23127762_ChIP-Seq_K562_Human | 2.67059249 |
14 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.59524116 |
15 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.58782583 |
16 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.58066738 |
17 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.54075976 |
18 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.46809790 |
19 | MAF_26560356_Chip-Seq_TH1_Human | 2.45645476 |
20 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.45588299 |
21 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.40850914 |
22 | UTX_26944678_Chip-Seq_JUKART_Human | 2.31632307 |
23 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 2.30470522 |
24 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.28228614 |
25 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.27483978 |
26 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.24687506 |
27 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.23066353 |
28 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.21930296 |
29 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 2.16365844 |
30 | MYB_26560356_Chip-Seq_TH2_Human | 2.16353118 |
31 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.12486706 |
32 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.08086361 |
33 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.07416019 |
34 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.07186986 |
35 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.00894170 |
36 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.00450942 |
37 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.99066678 |
38 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.98708516 |
39 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.97286636 |
40 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.97108909 |
41 | MYB_26560356_Chip-Seq_TH1_Human | 1.96483580 |
42 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.95269267 |
43 | MAF_26560356_Chip-Seq_TH2_Human | 1.94856319 |
44 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.91084472 |
45 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.90500336 |
46 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.89577954 |
47 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.88712737 |
48 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.86270048 |
49 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.85125742 |
50 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.84871253 |
51 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.82969624 |
52 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.78426968 |
53 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.70614904 |
54 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.67457054 |
55 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.66164455 |
56 | GATA1_19941826_ChIP-Seq_K562_Human | 1.65180194 |
57 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.62409290 |
58 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.61157349 |
59 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.61067981 |
60 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.60769875 |
61 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.57974898 |
62 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.56265919 |
63 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.51464080 |
64 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.51019126 |
65 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.50519251 |
66 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.50007379 |
67 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.49979638 |
68 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.49816574 |
69 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.49631419 |
70 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.49053902 |
71 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.49053902 |
72 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.48836781 |
73 | P68_20966046_ChIP-Seq_HELA_Human | 1.47391541 |
74 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.46580508 |
75 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.45498018 |
76 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45160198 |
77 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.44673535 |
78 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.43882229 |
79 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.43193531 |
80 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.42669979 |
81 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.41737978 |
82 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39911444 |
83 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.39074679 |
84 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.39065066 |
85 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.38880896 |
86 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.38536762 |
87 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.38259111 |
88 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.38010867 |
89 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.37222055 |
90 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.36798403 |
91 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.35771672 |
92 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.34681283 |
93 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.34563609 |
94 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.34196623 |
95 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.33996229 |
96 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.33433282 |
97 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.31946558 |
98 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.31348700 |
99 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.30810834 |
100 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.30110641 |
101 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.29654215 |
102 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.29601003 |
103 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.29502725 |
104 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.29482369 |
105 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.29447561 |
106 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.29226647 |
107 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.27244988 |
108 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25719332 |
109 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.25661874 |
110 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.25599652 |
111 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.24629055 |
112 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.23316543 |
113 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.23140812 |
114 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.22543279 |
115 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.21852753 |
116 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.21525830 |
117 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.21336050 |
118 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.20730813 |
119 | * KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.19791484 |
120 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.18500589 |
121 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.18249765 |
122 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.17843268 |
123 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.17257564 |
124 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.16435873 |
125 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.16026676 |
126 | MYC_22102868_ChIP-Seq_BL_Human | 1.15895133 |
127 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.15837060 |
128 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.15218882 |
129 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.14548453 |
130 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14179270 |
131 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.13463111 |
132 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.12185052 |
133 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12155730 |
134 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.11939746 |
135 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.11527406 |
136 | GATA2_19941826_ChIP-Seq_K562_Human | 1.11307482 |
137 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.10886591 |
138 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.10808042 |
139 | GATA1_22025678_ChIP-Seq_K562_Human | 1.10726966 |
140 | GATA3_26560356_Chip-Seq_TH2_Human | 1.10591627 |
141 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.09409923 |
142 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 1.08457105 |
143 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.07879600 |
144 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.07813223 |
145 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.07742754 |
146 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06467486 |
147 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.06125636 |
148 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.04166238 |
149 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.04100444 |
150 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.03725844 |
151 | SA1_27219007_Chip-Seq_Bcells_Human | 1.03633282 |
152 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.03605725 |
153 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01937825 |
154 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.01494488 |
155 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01317983 |
156 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00895367 |
157 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00133348 |
158 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.99736421 |
159 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.98788870 |
160 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.97715918 |
161 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97425928 |
162 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.97359106 |
163 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.97180849 |
164 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.97107819 |
165 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.96029041 |
166 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.94964019 |
167 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.94404862 |
168 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.94035814 |
169 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.92875984 |
170 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.91294316 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002837_dystrophic_cardiac_calcinosis | 4.77772900 |
2 | MP0003724_increased_susceptibility_to | 4.68637911 |
3 | MP0003646_muscle_fatigue | 4.63849072 |
4 | MP0003436_decreased_susceptibility_to | 4.30829953 |
5 | MP0000749_muscle_degeneration | 4.22371371 |
6 | MP0003303_peritoneal_inflammation | 3.93877193 |
7 | MP0000751_myopathy | 3.57749183 |
8 | MP0001835_abnormal_antigen_presentation | 3.16940658 |
9 | MP0002419_abnormal_innate_immunity | 3.06405947 |
10 | MP0003705_abnormal_hypodermis_morpholog | 3.04748442 |
11 | MP0002332_abnormal_exercise_endurance | 3.04278703 |
12 | MP0004185_abnormal_adipocyte_glucose | 2.98109462 |
13 | MP0004145_abnormal_muscle_electrophysio | 2.85206110 |
14 | MP0005025_abnormal_response_to | 2.77051020 |
15 | MP0004087_abnormal_muscle_fiber | 2.73351041 |
16 | MP0000685_abnormal_immune_system | 2.71157984 |
17 | MP0004084_abnormal_cardiac_muscle | 2.68350922 |
18 | MP0005387_immune_system_phenotype | 2.64960767 |
19 | MP0001790_abnormal_immune_system | 2.64960767 |
20 | MP0001800_abnormal_humoral_immune | 2.64627770 |
21 | MP0002269_muscular_atrophy | 2.63225653 |
22 | MP0005671_abnormal_response_to | 2.61962998 |
23 | MP0004036_abnormal_muscle_relaxation | 2.60970955 |
24 | MP0002132_abnormal_respiratory_system | 2.59975281 |
25 | MP0000750_abnormal_muscle_regeneration | 2.59647548 |
26 | MP0003656_abnormal_erythrocyte_physiolo | 2.57673124 |
27 | MP0005666_abnormal_adipose_tissue | 2.56231797 |
28 | MP0005330_cardiomyopathy | 2.54976827 |
29 | MP0005000_abnormal_immune_tolerance | 2.54658290 |
30 | MP0009785_altered_susceptibility_to | 2.53141269 |
31 | MP0000759_abnormal_skeletal_muscle | 2.48053564 |
32 | MP0004130_abnormal_muscle_cell | 2.48005403 |
33 | MP0004215_abnormal_myocardial_fiber | 2.43810258 |
34 | MP0008260_abnormal_autophagy | 2.43388939 |
35 | MP0002420_abnormal_adaptive_immunity | 2.42848986 |
36 | MP0001819_abnormal_immune_cell | 2.39986697 |
37 | MP0002723_abnormal_immune_serum | 2.39892728 |
38 | MP0002106_abnormal_muscle_physiology | 2.39477056 |
39 | MP0003300_gastrointestinal_ulcer | 2.38538730 |
40 | MP0006082_CNS_inflammation | 2.35680080 |
41 | MP0002254_reproductive_system_inflammat | 2.29947806 |
42 | MP0002452_abnormal_antigen_presenting | 2.25443194 |
43 | MP0005377_hearing/vestibular/ear_phenot | 2.14854871 |
44 | MP0003878_abnormal_ear_physiology | 2.14854871 |
45 | MP0005670_abnormal_white_adipose | 2.12902853 |
46 | MP0005464_abnormal_platelet_physiology | 2.12112883 |
47 | MP0005620_abnormal_muscle_contractility | 2.11568840 |
48 | MP0002405_respiratory_system_inflammati | 2.10655558 |
49 | MP0003011_delayed_dark_adaptation | 2.08044028 |
50 | MP0000747_muscle_weakness | 2.07812166 |
51 | MP0006036_abnormal_mitochondrial_physio | 2.06339206 |
52 | MP0001533_abnormal_skeleton_physiology | 2.06334883 |
53 | MP0003763_abnormal_thymus_physiology | 2.00536948 |
54 | MP0005369_muscle_phenotype | 1.98820675 |
55 | MP0002398_abnormal_bone_marrow | 1.98202567 |
56 | MP0006035_abnormal_mitochondrial_morpho | 1.93854539 |
57 | MP0005451_abnormal_body_composition | 1.91097378 |
58 | MP0003137_abnormal_impulse_conducting | 1.89257909 |
59 | MP0009278_abnormal_bone_marrow | 1.88465980 |
60 | MP0002148_abnormal_hypersensitivity_rea | 1.86098812 |
61 | MP0004858_abnormal_nervous_system | 1.82352685 |
62 | MP0000716_abnormal_immune_system | 1.80907915 |
63 | MP0004264_abnormal_extraembryonic_tissu | 1.78573556 |
64 | MP0010630_abnormal_cardiac_muscle | 1.78083378 |
65 | MP0008961_abnormal_basal_metabolism | 1.77963327 |
66 | MP0003172_abnormal_lysosome_physiology | 1.76865179 |
67 | MP0008775_abnormal_heart_ventricle | 1.74643131 |
68 | MP0002972_abnormal_cardiac_muscle | 1.72885473 |
69 | MP0003866_abnormal_defecation | 1.71386938 |
70 | MP0005397_hematopoietic_system_phenotyp | 1.70868566 |
71 | MP0001545_abnormal_hematopoietic_system | 1.70868566 |
72 | MP0002396_abnormal_hematopoietic_system | 1.65910999 |
73 | MP0005375_adipose_tissue_phenotype | 1.63066519 |
74 | MP0002722_abnormal_immune_system | 1.62747474 |
75 | MP0002277_abnormal_respiratory_mucosa | 1.62094474 |
76 | MP0005310_abnormal_salivary_gland | 1.61664219 |
77 | MP0003183_abnormal_peptide_metabolism | 1.59996040 |
78 | MP0010155_abnormal_intestine_physiology | 1.59972336 |
79 | MP0000689_abnormal_spleen_morphology | 1.57650685 |
80 | MP0001845_abnormal_inflammatory_respons | 1.54605987 |
81 | MP0009333_abnormal_splenocyte_physiolog | 1.53827938 |
82 | MP0002971_abnormal_brown_adipose | 1.52339702 |
83 | MP0004947_skin_inflammation | 1.51464274 |
84 | MP0002429_abnormal_blood_cell | 1.49999298 |
85 | MP0000703_abnormal_thymus_morphology | 1.49293906 |
86 | MP0005266_abnormal_metabolism | 1.48277406 |
87 | MP0009764_decreased_sensitivity_to | 1.46872434 |
88 | MP0004381_abnormal_hair_follicle | 1.46262343 |
89 | MP0001544_abnormal_cardiovascular_syste | 1.40252649 |
90 | MP0005385_cardiovascular_system_phenoty | 1.40252649 |
91 | MP0000343_altered_response_to | 1.36888290 |
92 | MP0008469_abnormal_protein_level | 1.35274604 |
93 | MP0003221_abnormal_cardiomyocyte_apopto | 1.35197022 |
94 | MP0006138_congestive_heart_failure | 1.32506436 |
95 | MP0003828_pulmonary_edema | 1.31151108 |
96 | MP0004484_altered_response_of | 1.30220024 |
97 | MP0000465_gastrointestinal_hemorrhage | 1.29717084 |
98 | MP0009115_abnormal_fat_cell | 1.26267951 |
99 | MP0002127_abnormal_cardiovascular_syste | 1.23336808 |
100 | MP0002970_abnormal_white_adipose | 1.23049125 |
101 | MP0004883_abnormal_blood_vessel | 1.18672175 |
102 | MP0001851_eye_inflammation | 1.18095333 |
103 | MP0004233_abnormal_muscle_weight | 1.17857263 |
104 | MP0002108_abnormal_muscle_morphology | 1.16969352 |
105 | MP0004043_abnormal_pH_regulation | 1.14939630 |
106 | MP0001849_ear_inflammation | 1.09832825 |
107 | MP0004085_abnormal_heartbeat | 1.09264920 |
108 | MP0005319_abnormal_enzyme/_coenzyme | 1.08198937 |
109 | MP0004147_increased_porphyrin_level | 1.07954023 |
110 | MP0003075_altered_response_to | 1.05516362 |
111 | MP0005257_abnormal_intraocular_pressure | 1.04954390 |
112 | MP0010352_gastrointestinal_tract_polyps | 1.04904339 |
113 | MP0000858_altered_metastatic_potential | 1.04588808 |
114 | MP0000733_abnormal_muscle_development | 1.03501612 |
115 | MP0002998_abnormal_bone_remodeling | 1.01951093 |
116 | MP0003806_abnormal_nucleotide_metabolis | 1.01795213 |
117 | MP0005410_abnormal_fertilization | 1.00942570 |
118 | MP0005164_abnormal_response_to | 0.98737385 |
119 | MP0001986_abnormal_taste_sensitivity | 0.98065042 |
120 | MP0000490_abnormal_crypts_of | 0.97177655 |
121 | MP0000266_abnormal_heart_morphology | 0.94998193 |
122 | MP0001873_stomach_inflammation | 0.91806218 |
123 | MP0000015_abnormal_ear_pigmentation | 0.91117921 |
124 | MP0003045_fibrosis | 0.88407726 |
125 | MP0002653_abnormal_ependyma_morphology | 0.87569870 |
126 | MP0008004_abnormal_stomach_pH | 0.85527166 |
127 | MP0005166_decreased_susceptibility_to | 0.85156351 |
128 | MP0003690_abnormal_glial_cell | 0.83883685 |
129 | MP0001663_abnormal_digestive_system | 0.83464771 |
130 | MP0010329_abnormal_lipoprotein_level | 0.82808816 |
131 | MP0000609_abnormal_liver_physiology | 0.81424513 |
132 | MP0003950_abnormal_plasma_membrane | 0.81121751 |
133 | MP0004808_abnormal_hematopoietic_stem | 0.80579602 |
134 | MP0005083_abnormal_biliary_tract | 0.80283066 |
135 | MP0003566_abnormal_cell_adhesion | 0.79532583 |
136 | MP0003191_abnormal_cellular_cholesterol | 0.79154408 |
137 | MP0002088_abnormal_embryonic_growth/wei | 0.79061628 |
138 | MP0003984_embryonic_growth_retardation | 0.78556845 |
139 | MP0008770_decreased_survivor_rate | 0.78477607 |
140 | MP0005390_skeleton_phenotype | 0.76969262 |
141 | MP0009840_abnormal_foam_cell | 0.76301384 |
142 | MP0005167_abnormal_blood-brain_barrier | 0.75578218 |
143 | MP0005499_abnormal_olfactory_system | 0.74212077 |
144 | MP0005394_taste/olfaction_phenotype | 0.74212077 |
145 | MP0000003_abnormal_adipose_tissue | 0.74057869 |
146 | MP0009763_increased_sensitivity_to | 0.73827503 |
147 | MP0005248_abnormal_Harderian_gland | 0.73286519 |
148 | MP0005275_abnormal_skin_tensile | 0.72879898 |
149 | MP0002118_abnormal_lipid_homeostasis | 0.71617144 |
150 | MP0008874_decreased_physiological_sensi | 0.71279942 |
151 | MP0009765_abnormal_xenobiotic_induced | 0.69632238 |
152 | MP0005452_abnormal_adipose_tissue | 0.69601602 |
153 | MP0003279_aneurysm | 0.69095942 |
154 | MP0002877_abnormal_melanocyte_morpholog | 0.68908718 |
155 | MP0005380_embryogenesis_phenotype | 0.68785858 |
156 | MP0001672_abnormal_embryogenesis/_devel | 0.68785858 |
157 | MP0002138_abnormal_hepatobiliary_system | 0.68773940 |
158 | MP0005360_urolithiasis | 0.68390186 |
159 | MP0005448_abnormal_energy_balance | 0.66819048 |
160 | MP0000762_abnormal_tongue_morphology | 0.66777337 |
161 | MP0005334_abnormal_fat_pad | 0.65755045 |
162 | MP0002078_abnormal_glucose_homeostasis | 0.64820757 |
163 | MP0005023_abnormal_wound_healing | 0.64356737 |
164 | MP0002925_abnormal_cardiovascular_devel | 0.63467026 |
165 | MP0005075_abnormal_melanosome_morpholog | 0.62682237 |
166 | MP0003448_altered_tumor_morphology | 0.61645424 |
167 | MP0002796_impaired_skin_barrier | 0.61505718 |
168 | MP0000678_abnormal_parathyroid_gland | 0.60935139 |
169 | MP0002166_altered_tumor_susceptibility | 0.60139475 |
170 | MP0005376_homeostasis/metabolism_phenot | 0.59915355 |
171 | MP0005623_abnormal_meninges_morphology | 0.59706368 |
172 | MP0003795_abnormal_bone_structure | 0.58692487 |
173 | MP0002909_abnormal_adrenal_gland | 0.58618307 |
174 | MP0003890_abnormal_embryonic-extraembry | 0.58376907 |
175 | MP0002928_abnormal_bile_duct | 0.58260243 |
176 | MP0000249_abnormal_blood_vessel | 0.54862996 |
177 | MP0002933_joint_inflammation | 0.54307704 |
178 | MP0004510_myositis | 0.54101907 |
179 | MP0005085_abnormal_gallbladder_physiolo | 0.53971986 |
180 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.53883178 |
181 | MP0000604_amyloidosis | 0.49531859 |
182 | MP0000470_abnormal_stomach_morphology | 0.48518894 |
183 | MP0005058_abnormal_lysosome_morphology | 0.46942369 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Eczematoid dermatitis (HP:0000976) | 6.55066045 |
2 | Exercise-induced muscle cramps (HP:0003710) | 6.45524361 |
3 | Exercise-induced myalgia (HP:0003738) | 6.28861965 |
4 | Difficulty running (HP:0009046) | 5.76875674 |
5 | Recurrent abscess formation (HP:0002722) | 5.74633688 |
6 | Myositis (HP:0100614) | 5.63638580 |
7 | Recurrent bacterial skin infections (HP:0005406) | 5.55219181 |
8 | Increased connective tissue (HP:0009025) | 5.46618305 |
9 | Myoglobinuria (HP:0002913) | 5.37478920 |
10 | Orchitis (HP:0100796) | 5.31054007 |
11 | Abnormality of macrophages (HP:0004311) | 5.23805494 |
12 | Stomatitis (HP:0010280) | 4.83644870 |
13 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.81528176 |
14 | Optic neuritis (HP:0100653) | 4.80473283 |
15 | Retrobulbar optic neuritis (HP:0100654) | 4.80473283 |
16 | Microcytic anemia (HP:0001935) | 4.62180758 |
17 | Gastrointestinal infarctions (HP:0005244) | 4.54846555 |
18 | Hypochromic microcytic anemia (HP:0004840) | 4.46102884 |
19 | Hyporeflexia of lower limbs (HP:0002600) | 4.38122696 |
20 | Muscle fiber splitting (HP:0003555) | 4.34838352 |
21 | Ventricular tachycardia (HP:0004756) | 4.33953364 |
22 | Muscle fiber inclusion bodies (HP:0100299) | 4.32938264 |
23 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.31587523 |
24 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.28705345 |
25 | Obstructive lung disease (HP:0006536) | 4.21395666 |
26 | Chronic obstructive pulmonary disease (HP:0006510) | 4.21395666 |
27 | Sudden death (HP:0001699) | 4.20078527 |
28 | Calf muscle hypertrophy (HP:0008981) | 4.18487720 |
29 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.14256642 |
30 | Rhabdomyolysis (HP:0003201) | 4.06306591 |
31 | Type 1 muscle fiber predominance (HP:0003803) | 3.99696664 |
32 | EMG: myopathic abnormalities (HP:0003458) | 3.84605116 |
33 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.81074926 |
34 | Spontaneous hematomas (HP:0007420) | 3.76410473 |
35 | Increased IgE level (HP:0003212) | 3.76041425 |
36 | Muscle stiffness (HP:0003552) | 3.75634805 |
37 | Prolonged bleeding time (HP:0003010) | 3.75576054 |
38 | Recurrent fungal infections (HP:0002841) | 3.74533715 |
39 | Urticaria (HP:0001025) | 3.73896098 |
40 | Meningitis (HP:0001287) | 3.72624666 |
41 | Mediastinal lymphadenopathy (HP:0100721) | 3.66610296 |
42 | Multiple enchondromatosis (HP:0005701) | 3.66099343 |
43 | Recurrent skin infections (HP:0001581) | 3.63259637 |
44 | Gingivitis (HP:0000230) | 3.61709657 |
45 | Encephalitis (HP:0002383) | 3.53903264 |
46 | Testicular atrophy (HP:0000029) | 3.53859493 |
47 | Increased variability in muscle fiber diameter (HP:0003557) | 3.53039940 |
48 | Nemaline bodies (HP:0003798) | 3.50419567 |
49 | Keratoconjunctivitis sicca (HP:0001097) | 3.48339574 |
50 | Abnormal hemoglobin (HP:0011902) | 3.37577541 |
51 | Difficulty climbing stairs (HP:0003551) | 3.36442945 |
52 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.36036907 |
53 | Bilateral microphthalmos (HP:0007633) | 3.31329641 |
54 | Mildly elevated creatine phosphokinase (HP:0008180) | 3.29765801 |
55 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.29104250 |
56 | Abnormality of the calf musculature (HP:0001430) | 3.27862020 |
57 | Vasculitis (HP:0002633) | 3.25914691 |
58 | Myotonia (HP:0002486) | 3.22813662 |
59 | Keratoconjunctivitis (HP:0001096) | 3.22080792 |
60 | Episodic fever (HP:0001954) | 3.21386256 |
61 | Cellulitis (HP:0100658) | 3.20256514 |
62 | Abnormality of the lower motor neuron (HP:0002366) | 3.18567668 |
63 | Chest pain (HP:0100749) | 3.14943096 |
64 | Myopathic facies (HP:0002058) | 3.14458668 |
65 | Reticulocytosis (HP:0001923) | 3.11714087 |
66 | Toxemia of pregnancy (HP:0100603) | 3.09600297 |
67 | Peritonitis (HP:0002586) | 3.08063131 |
68 | EMG: neuropathic changes (HP:0003445) | 3.05834962 |
69 | Recurrent cutaneous fungal infections (HP:0011370) | 3.05589699 |
70 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.05589699 |
71 | Cholelithiasis (HP:0001081) | 3.04082361 |
72 | Gingival bleeding (HP:0000225) | 3.00526489 |
73 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.99814782 |
74 | Subaortic stenosis (HP:0001682) | 2.99814782 |
75 | Ragged-red muscle fibers (HP:0003200) | 2.96864271 |
76 | Round ear (HP:0100830) | 2.96314205 |
77 | Inflammation of the large intestine (HP:0002037) | 2.93573678 |
78 | Asymmetric septal hypertrophy (HP:0001670) | 2.91797789 |
79 | Distal arthrogryposis (HP:0005684) | 2.88747526 |
80 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.86295999 |
81 | Gastrointestinal inflammation (HP:0004386) | 2.84710142 |
82 | Pustule (HP:0200039) | 2.84472445 |
83 | Ulnar deviation of the wrist (HP:0003049) | 2.79112184 |
84 | Anorexia (HP:0002039) | 2.78685793 |
85 | Epistaxis (HP:0000421) | 2.73581708 |
86 | Petechiae (HP:0000967) | 2.71239396 |
87 | Paralysis (HP:0003470) | 2.71114123 |
88 | Leukocytosis (HP:0001974) | 2.70544176 |
89 | Progressive muscle weakness (HP:0003323) | 2.66498837 |
90 | Hepatoblastoma (HP:0002884) | 2.65001958 |
91 | Achilles tendon contracture (HP:0001771) | 2.64255837 |
92 | Slow saccadic eye movements (HP:0000514) | 2.63876788 |
93 | Abnormal gallbladder morphology (HP:0012437) | 2.63061092 |
94 | Pulmonary infiltrates (HP:0002113) | 2.61506971 |
95 | Right ventricular cardiomyopathy (HP:0011663) | 2.61119602 |
96 | Atrial fibrillation (HP:0005110) | 2.60838260 |
97 | Severe visual impairment (HP:0001141) | 2.58243885 |
98 | Osteomyelitis (HP:0002754) | 2.57670853 |
99 | Hemoptysis (HP:0002105) | 2.56775896 |
100 | Hyperglycinuria (HP:0003108) | 2.55372729 |
101 | T lymphocytopenia (HP:0005403) | 2.50420191 |
102 | Arterial thrombosis (HP:0004420) | 2.48862849 |
103 | Poikilocytosis (HP:0004447) | 2.48077631 |
104 | Abnormality of the Achilles tendon (HP:0005109) | 2.46358938 |
105 | Lipoatrophy (HP:0100578) | 2.45693551 |
106 | Primary atrial arrhythmia (HP:0001692) | 2.44205875 |
107 | Increased IgM level (HP:0003496) | 2.39759248 |
108 | Bundle branch block (HP:0011710) | 2.39501334 |
109 | Abnormality of T cell number (HP:0011839) | 2.39489674 |
110 | Pulmonary embolism (HP:0002204) | 2.39442769 |
111 | Abnormal cartilage morphology (HP:0002763) | 2.39364265 |
112 | Nasal polyposis (HP:0100582) | 2.37882469 |
113 | Abnormality of T cells (HP:0002843) | 2.37074048 |
114 | Distal lower limb muscle weakness (HP:0009053) | 2.34200359 |
115 | Supraventricular tachycardia (HP:0004755) | 2.33367482 |
116 | Dilated cardiomyopathy (HP:0001644) | 2.30152301 |
117 | Areflexia of lower limbs (HP:0002522) | 2.28989278 |
118 | Supraventricular arrhythmia (HP:0005115) | 2.28160620 |
119 | Neck muscle weakness (HP:0000467) | 2.24723955 |
120 | Abnormality of T cell physiology (HP:0011840) | 2.19877478 |
121 | Amyloidosis (HP:0011034) | 2.19217670 |
122 | Granulocytopenia (HP:0001913) | 2.19169096 |
123 | Rib fusion (HP:0000902) | 2.18821281 |
124 | Panhypogammaglobulinemia (HP:0003139) | 2.18782886 |
125 | Ventricular arrhythmia (HP:0004308) | 2.18778306 |
126 | Abnormality of iron homeostasis (HP:0011031) | 2.18550785 |
127 | Lymphopenia (HP:0001888) | 2.18517924 |
128 | Abnormality of the pericardium (HP:0001697) | 2.18325146 |
129 | Ketoacidosis (HP:0001993) | 2.16224046 |
130 | Glomerulopathy (HP:0100820) | 2.15387731 |
131 | Sepsis (HP:0100806) | 2.15079384 |
132 | Recurrent viral infections (HP:0004429) | 2.14221404 |
133 | Abnormal atrioventricular conduction (HP:0005150) | 2.09887291 |
134 | Abnormality of the peritoneum (HP:0002585) | 2.09057042 |
135 | Abnormality of the pubic bones (HP:0003172) | 2.08353444 |
136 | Abnormal platelet volume (HP:0011876) | 2.08235764 |
137 | Acne (HP:0001061) | 2.08158265 |
138 | Hypoplastic ischia (HP:0003175) | 2.07985373 |
139 | Hamartoma of the eye (HP:0010568) | 2.07213283 |
140 | Increased serum ferritin (HP:0003281) | 2.06622626 |
141 | Purpura (HP:0000979) | 2.05852901 |
142 | Abnormality of the salivary glands (HP:0010286) | 2.05114705 |
143 | Metaphyseal cupping (HP:0003021) | 2.04053855 |
144 | Hypochromic anemia (HP:0001931) | 2.03346465 |
145 | Abnormality of the pleura (HP:0002103) | 2.03144117 |
146 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.02137176 |
147 | Hypergammaglobulinemia (HP:0010702) | 2.00785132 |
148 | Ependymoma (HP:0002888) | 2.00578099 |
149 | Recurrent pneumonia (HP:0006532) | 1.99595621 |
150 | Heart block (HP:0012722) | 1.99293284 |
151 | Facial diplegia (HP:0001349) | 1.98778192 |
152 | Skin nodule (HP:0200036) | 1.98402795 |
153 | IgM deficiency (HP:0002850) | 1.98077452 |
154 | Distal lower limb amyotrophy (HP:0008944) | 1.97855153 |
155 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.96062699 |
156 | Generalized muscle weakness (HP:0003324) | 1.93261690 |
157 | Abnormality of the nasal mucosa (HP:0000433) | 1.93118791 |
158 | Palpitations (HP:0001962) | 1.92357417 |
159 | Atrioventricular block (HP:0001678) | 1.90865260 |
160 | Resting tremor (HP:0002322) | 1.89792880 |
161 | Hepatosplenomegaly (HP:0001433) | 1.89760253 |
162 | Gangrene (HP:0100758) | 1.89394253 |
163 | Dicarboxylic aciduria (HP:0003215) | 1.89105831 |
164 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.89105831 |
165 | Vertigo (HP:0002321) | 1.88979424 |
166 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.86433283 |
167 | Colitis (HP:0002583) | 1.85852255 |
168 | Malnutrition (HP:0004395) | 1.85716445 |
169 | Skin ulcer (HP:0200042) | 1.84989065 |
170 | Polycythemia (HP:0001901) | 1.81551396 |
171 | Recurrent lower respiratory tract infections (HP:0002783) | 1.81141190 |
172 | Acute hepatic failure (HP:0006554) | 1.80981784 |
173 | Abnormality of glycine metabolism (HP:0010895) | 1.80352653 |
174 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.80352653 |
175 | Distal upper limb amyotrophy (HP:0007149) | 1.80324422 |
176 | Upper limb amyotrophy (HP:0009129) | 1.80324422 |
177 | Abnormality of the fingertips (HP:0001211) | 1.79776791 |
178 | Abnormality of the ischium (HP:0003174) | 1.78180155 |
179 | Ulnar bowing (HP:0003031) | 1.77724555 |
180 | Abnormality of the endocardium (HP:0004306) | 1.77540550 |
181 | Hypoalphalipoproteinemia (HP:0003233) | 1.76561092 |
182 | Ketosis (HP:0001946) | 1.76341740 |
183 | Premature loss of primary teeth (HP:0006323) | 1.75369800 |
184 | Splenomegaly (HP:0001744) | 1.74969999 |
185 | Keratitis (HP:0000491) | 1.74197427 |
186 | Difficulty walking (HP:0002355) | 1.73412017 |
187 | Abnormal gallbladder physiology (HP:0012438) | 1.72662433 |
188 | Cholecystitis (HP:0001082) | 1.72662433 |
189 | Diaphragmatic weakness (HP:0009113) | 1.72592857 |
190 | Frequent falls (HP:0002359) | 1.71887643 |
191 | Gout (HP:0001997) | 1.69499200 |
192 | Generalized amyotrophy (HP:0003700) | 1.69338377 |
Rank | Gene Set | Z-score |
---|---|---|
1 | CDK12 | 4.98489418 |
2 | RIPK4 | 4.54491714 |
3 | ERN1 | 3.97597293 |
4 | TTN | 3.71384786 |
5 | MAP4K1 | 3.52399254 |
6 | GRK5 | 3.22430008 |
7 | IRAK4 | 3.20449437 |
8 | TRIB3 | 3.08789742 |
9 | OBSCN | 2.86765441 |
10 | PDK3 | 2.85551469 |
11 | PDK4 | 2.85551469 |
12 | TNK2 | 2.82649892 |
13 | PHKG2 | 2.65026910 |
14 | PHKG1 | 2.65026910 |
15 | BLK | 2.63493058 |
16 | GRK6 | 2.54472813 |
17 | FES | 2.29013400 |
18 | TYK2 | 2.24617407 |
19 | TGFBR2 | 2.23560927 |
20 | PRPF4B | 1.99028899 |
21 | ZAP70 | 1.84455426 |
22 | BCKDK | 1.81268107 |
23 | HCK | 1.79066752 |
24 | ICK | 1.78676793 |
25 | PDK2 | 1.75585858 |
26 | TYRO3 | 1.72761739 |
27 | GRK7 | 1.63252682 |
28 | MAP3K1 | 1.60865776 |
29 | FGR | 1.60421815 |
30 | BTK | 1.59925849 |
31 | MAP3K10 | 1.52708097 |
32 | MAP3K7 | 1.52119067 |
33 | SYK | 1.50272265 |
34 | JAK3 | 1.49824516 |
35 | WNK1 | 1.46849246 |
36 | PKN2 | 1.43086605 |
37 | MAP2K3 | 1.42850821 |
38 | TXK | 1.40758641 |
39 | STK10 | 1.40146789 |
40 | CSF1R | 1.39608588 |
41 | RIPK1 | 1.38424832 |
42 | MAPK7 | 1.38086876 |
43 | SIK3 | 1.35441769 |
44 | GRK1 | 1.35146168 |
45 | MAP2K4 | 1.34618557 |
46 | NEK1 | 1.33399922 |
47 | PRKG2 | 1.33038003 |
48 | MAPK12 | 1.32499541 |
49 | PINK1 | 1.32083064 |
50 | IKBKE | 1.30010198 |
51 | LMTK2 | 1.29443138 |
52 | DMPK | 1.26924653 |
53 | LYN | 1.20984939 |
54 | MARK3 | 1.18967934 |
55 | TAOK1 | 1.18030854 |
56 | SIK2 | 1.16324602 |
57 | MOS | 1.13293608 |
58 | MATK | 1.10290872 |
59 | YES1 | 1.09456380 |
60 | TBK1 | 1.09337042 |
61 | TAOK3 | 1.08879115 |
62 | CAMK4 | 1.08861467 |
63 | MAPKAPK3 | 1.07273675 |
64 | PRKAA1 | 1.06280061 |
65 | SIK1 | 1.03739309 |
66 | MAP2K6 | 1.03473195 |
67 | TTK | 1.02905211 |
68 | NME1 | 1.00880253 |
69 | CDK19 | 0.99707238 |
70 | LCK | 0.98652914 |
71 | ADRBK2 | 0.93848462 |
72 | TESK2 | 0.93328045 |
73 | BMX | 0.91632872 |
74 | SMG1 | 0.91259012 |
75 | PRKAA2 | 0.91242700 |
76 | PRKD3 | 0.90467889 |
77 | DDR2 | 0.83496963 |
78 | MARK2 | 0.83444239 |
79 | JAK1 | 0.81281378 |
80 | MAP3K2 | 0.80157742 |
81 | STK11 | 0.80011872 |
82 | AKT2 | 0.79113965 |
83 | SGK3 | 0.78712344 |
84 | MAP3K13 | 0.78012870 |
85 | MAP3K3 | 0.77997443 |
86 | PAK4 | 0.77793114 |
87 | PDGFRA | 0.77180508 |
88 | STK38 | 0.76743526 |
89 | DYRK1B | 0.74275410 |
90 | ITK | 0.73176143 |
91 | NTRK1 | 0.71190389 |
92 | MAP3K14 | 0.70109624 |
93 | IRAK2 | 0.68431051 |
94 | IKBKB | 0.68364496 |
95 | PIK3CG | 0.68195050 |
96 | MTOR | 0.67429579 |
97 | IRAK1 | 0.66744963 |
98 | PIM1 | 0.66081767 |
99 | LATS2 | 0.64776581 |
100 | KIT | 0.63748484 |
101 | MAP3K11 | 0.61694276 |
102 | FYN | 0.61399139 |
103 | MAPK11 | 0.60618396 |
104 | CAMK1D | 0.59842999 |
105 | RPS6KL1 | 0.59638455 |
106 | RPS6KC1 | 0.59638455 |
107 | DYRK3 | 0.57849355 |
108 | FGFR3 | 0.56990950 |
109 | PDK1 | 0.56101321 |
110 | SGK2 | 0.56007918 |
111 | CSK | 0.55465845 |
112 | LRRK2 | 0.53729556 |
113 | TRPM7 | 0.52089376 |
114 | RPS6KA6 | 0.51463522 |
115 | MAP3K8 | 0.51354989 |
116 | STK4 | 0.50725948 |
117 | PRKCQ | 0.49736814 |
118 | EPHB1 | 0.48686196 |
119 | TEC | 0.48670860 |
120 | ADRBK1 | 0.48354102 |
121 | PRKD1 | 0.47758842 |
122 | PTK2 | 0.46375158 |
123 | PDPK1 | 0.46089311 |
124 | ALK | 0.45411615 |
125 | MAPKAPK2 | 0.44794081 |
126 | PRKACG | 0.44471002 |
127 | DAPK2 | 0.44200092 |
128 | PRKCZ | 0.43493910 |
129 | HIPK2 | 0.43099573 |
130 | KSR1 | 0.42806209 |
131 | PRKD2 | 0.41111986 |
132 | RAF1 | 0.40053178 |
133 | PAK3 | 0.38897130 |
134 | TESK1 | 0.38851708 |
135 | RPS6KA2 | 0.38499516 |
136 | PAK6 | 0.37792071 |
137 | MYLK | 0.36235745 |
138 | EEF2K | 0.36047474 |
139 | RET | 0.35792723 |
140 | PIK3CA | 0.35218152 |
141 | BMPR2 | 0.35125310 |
142 | RPS6KA1 | 0.35123334 |
143 | TAOK2 | 0.33207195 |
144 | SGK494 | 0.32913259 |
145 | SGK223 | 0.32913259 |
146 | MAP3K5 | 0.31324549 |
147 | PTK2B | 0.30250011 |
148 | MAP3K6 | 0.29745895 |
149 | PRKACB | 0.29510465 |
150 | STK24 | 0.29143065 |
151 | PTK6 | 0.29078372 |
152 | CAMK1G | 0.28282146 |
153 | CDK7 | 0.27669976 |
154 | MUSK | 0.27481010 |
155 | PRKCH | 0.27246028 |
156 | RPS6KA3 | 0.26407903 |
157 | JAK2 | 0.26162070 |
158 | KSR2 | 0.24642042 |
159 | GSK3A | 0.24215090 |
160 | MAPK4 | 0.23147472 |
161 | TIE1 | 0.21814115 |
162 | LATS1 | 0.21537700 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.50698696 |
2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.53586761 |
3 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 3.18764559 |
4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 3.02785978 |
5 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.77823398 |
6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.71248472 |
7 | Leishmaniasis_Homo sapiens_hsa05140 | 2.69745328 |
8 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.61313163 |
9 | Malaria_Homo sapiens_hsa05144 | 2.49368317 |
10 | Carbon metabolism_Homo sapiens_hsa01200 | 2.48702472 |
11 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.45412120 |
12 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.43946919 |
13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.41134890 |
14 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.29566959 |
15 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.24590609 |
16 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.18229902 |
17 | Galactose metabolism_Homo sapiens_hsa00052 | 2.17181568 |
18 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.15234918 |
19 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.10735083 |
20 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.07859387 |
21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.07792250 |
22 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 2.05292740 |
23 | Tuberculosis_Homo sapiens_hsa05152 | 2.04619185 |
24 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.02890042 |
25 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.98522978 |
26 | Allograft rejection_Homo sapiens_hsa05330 | 1.98394756 |
27 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.91195245 |
28 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.90379782 |
29 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.87327110 |
30 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.86088449 |
31 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.81578306 |
32 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.79669500 |
33 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.74145674 |
34 | Measles_Homo sapiens_hsa05162 | 1.73665884 |
35 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.70443865 |
36 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.64185597 |
37 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.63329554 |
38 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.63053893 |
39 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.60859519 |
40 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.56459192 |
41 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.55473808 |
42 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.51612936 |
43 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.48932797 |
44 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.47081612 |
45 | Influenza A_Homo sapiens_hsa05164 | 1.44912983 |
46 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.44626970 |
47 | Insulin resistance_Homo sapiens_hsa04931 | 1.44125354 |
48 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.43733190 |
49 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.41333346 |
50 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.40565545 |
51 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.39137391 |
52 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.34458302 |
53 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.33200131 |
54 | Phagosome_Homo sapiens_hsa04145 | 1.32968109 |
55 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.30987472 |
56 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.29937253 |
57 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.27981450 |
58 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.23641631 |
59 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.21649515 |
60 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.21307900 |
61 | Legionellosis_Homo sapiens_hsa05134 | 1.19157845 |
62 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.17106817 |
63 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.15297462 |
64 | Platelet activation_Homo sapiens_hsa04611 | 1.12852850 |
65 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.12473113 |
66 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.11349272 |
67 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.11126644 |
68 | Hepatitis B_Homo sapiens_hsa05161 | 1.10774023 |
69 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.09539529 |
70 | Endocytosis_Homo sapiens_hsa04144 | 1.08149114 |
71 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.05812017 |
72 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.05648198 |
73 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.05236325 |
74 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.05171504 |
75 | Hepatitis C_Homo sapiens_hsa05160 | 1.04497539 |
76 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.00142127 |
77 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.99521301 |
78 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.98475225 |
79 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.97547725 |
80 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.95052587 |
81 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.94566880 |
82 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.94121986 |
83 | Apoptosis_Homo sapiens_hsa04210 | 0.93984201 |
84 | Lysine degradation_Homo sapiens_hsa00310 | 0.93228313 |
85 | Shigellosis_Homo sapiens_hsa05131 | 0.89832396 |
86 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.89576021 |
87 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.88372840 |
88 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.88301612 |
89 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.85959661 |
90 | Bile secretion_Homo sapiens_hsa04976 | 0.85631396 |
91 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.85570572 |
92 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.85546467 |
93 | Endometrial cancer_Homo sapiens_hsa05213 | 0.85380926 |
94 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.84309941 |
95 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.82233043 |
96 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.81003947 |
97 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.79955438 |
98 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.79757128 |
99 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.79171557 |
100 | Salmonella infection_Homo sapiens_hsa05132 | 0.79030732 |
101 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.78160635 |
102 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.76228945 |
103 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.75657776 |
104 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.72602064 |
105 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.71713081 |
106 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.71559334 |
107 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.71266989 |
108 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.70873709 |
109 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.70568044 |
110 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.70298814 |
111 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.68278590 |
112 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.67910176 |
113 | Bladder cancer_Homo sapiens_hsa05219 | 0.66790156 |
114 | ABC transporters_Homo sapiens_hsa02010 | 0.66716784 |
115 | Pertussis_Homo sapiens_hsa05133 | 0.66381416 |
116 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.64398960 |
117 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.64096635 |
118 | Colorectal cancer_Homo sapiens_hsa05210 | 0.64077967 |
119 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.63036869 |
120 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.62583885 |
121 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.60696580 |
122 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.60661870 |
123 | Sulfur relay system_Homo sapiens_hsa04122 | 0.60595197 |
124 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.59514892 |
125 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.59156627 |
126 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.58996831 |
127 | Focal adhesion_Homo sapiens_hsa04510 | 0.58365895 |
128 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.56228534 |
129 | Other glycan degradation_Homo sapiens_hsa00511 | 0.55226684 |
130 | HTLV-I infection_Homo sapiens_hsa05166 | 0.53675084 |
131 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.53620107 |
132 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.53295953 |
133 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.52882003 |
134 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.51132103 |
135 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.49452166 |
136 | Thyroid cancer_Homo sapiens_hsa05216 | 0.49362181 |
137 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.48727027 |
138 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.48344477 |
139 | Amoebiasis_Homo sapiens_hsa05146 | 0.47988842 |
140 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.47827901 |
141 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.47689991 |
142 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.46807412 |
143 | Viral myocarditis_Homo sapiens_hsa05416 | 0.46646576 |
144 | Prostate cancer_Homo sapiens_hsa05215 | 0.46613738 |
145 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.45776766 |
146 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.45712491 |
147 | Lysosome_Homo sapiens_hsa04142 | 0.45157245 |
148 | * Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.44611870 |
149 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.44547027 |
150 | Asthma_Homo sapiens_hsa05310 | 0.44280057 |
151 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.43890795 |
152 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.43773590 |
153 | Tight junction_Homo sapiens_hsa04530 | 0.43240112 |
154 | Glioma_Homo sapiens_hsa05214 | 0.42331953 |
155 | Parkinsons disease_Homo sapiens_hsa05012 | 0.42184445 |
156 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.41696288 |
157 | Peroxisome_Homo sapiens_hsa04146 | 0.41326337 |
158 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.38574163 |
159 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.38042364 |
160 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.36769192 |
161 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.36048995 |
162 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.34772508 |
163 | Alzheimers disease_Homo sapiens_hsa05010 | 0.33232231 |
164 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.32759971 |
165 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.32583461 |
166 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.32058985 |
167 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.31101946 |
168 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.29981404 |
169 | Renin secretion_Homo sapiens_hsa04924 | 0.25652207 |
170 | Adherens junction_Homo sapiens_hsa04520 | 0.25527984 |
171 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.25457715 |
172 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.23714319 |
173 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.23440697 |
174 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.23186596 |
175 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.22417681 |
176 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.21017452 |
177 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.20557481 |